NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
Oct 27, 2025, 8:00 PM EDT
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $2.49 million as of October 29, 2025. Its market cap has decreased by -82.33% in one year.
Market Cap
2.49M
Enterprise Value
55.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 2.49M, a decrease of -99.26%. That is a compound annual growth rate of -88.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 2.49M | -89.46% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 668.66M |
| Glass House Brands | 588.69M |
| Northwest Biotherapeutics | 394.58M |
| Silence Therapeutics | 337.25M |
| CytoDyn | 320.50M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 291.52M |